Skip to Content

Editas Medicine

EDIT

Buy $EDIT at eToro
Rank 3233
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 11 HURLEY ST., CAMBRIDGE, MA, US

Editas Medicine - Key figures

Market cap 834.68 Million
Revenue 25.82 Million
Profit -116,963,000
P/E Ratio No information
P/s Ratio 32.31
Buy $EDIT at eToro

Editas Medicine - Description

Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases.

The company is headquartered in Cambridge, Massachusetts.